Stem cell therapy for neonatal hypoxia-ischemia
| Project/Area Number |
23791229
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Embryonic/Neonatal medicine
|
|---|
| Research Institution | Ehime University |
|---|
Principal Investigator |
ZHU Pengxiang 愛媛大学, 医学(系)研究科(研究院), 助教 (40380216)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2013: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | 新生児医学 / 脳性麻痺 / 再生医学 / 胚性幹細胞 / 神経前駆細胞 / ＥＳ細胞 / 再生療法 / ES細胞 |
|---|
| Research Abstract |
Neonatal hypoxic-ischemic insult is one of the most significant cause of pediatric encephalopathy and spastic cerebral palsy. Although the developing brain's plasticity allows for remarkable self-repair, severe disruption of normal myelination and cortical development upon neonatal brain injury are likely to generate life-persisting sensory-motor and cognitive deficits in the growing child. Currently, no treatments are available that can address the long-term consequences. Thus, regenerative medicine appears as a promising avenue to help restore normal developmental processes in affected infants. Here we have demonstrated that neural stem cells derived from embryonic stem cells have shown protective effects on hypoxic-ischemic insults. Our results have suggested that stem cell therapy has proven effective in promoting functional recovery in animal models of neonatal hypoxic-ischemic injury and therefore represents a hopeful therapy for this unmet medical condition.
|
Report
(4 results)
Research Products
(7 results)
